Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

112.94
Delayed Data
As of Dec 06
 +2.99 / +2.72%
Today’s Change
67.81
Today|||52-Week Range
132.95
+25.10%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close109.95
Today’s open109.62
Day’s range109.53 - 114.68
Volume781,447
Average volume (3 months)495,426
Market cap$4.8B
Dividend yield--
Data as of 3:59pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+33.33%
Earnings growth (next 5 years)+25.50%
Revenue growth (last year)+43.09%
P/E ratio116.4
Price/Sales12.92
Price/Book12.70

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+1.03+1.60%
WSTWest Pharmaceutical ...+1.93+2.37%
CMDCantel Medical Corp+3.36+4.07%
NUVANuVasive Inc+0.77+1.17%
Data as of 4:02pm ET, 12/06/2016

Financials

Next reporting dateFebruary 9, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts


Search for Jobs